CELATOR PHARMACEUTICALS INC's ticker is CPXX and the CUSIP is 15089R102. A total of 15 filers reported holding CELATOR PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $25,696,000 | +3712.5% | 851,430 | +1293.0% | 0.01% | – |
| Q1 2016 | $674,000 | +481.0% | 61,121 | -7.4% | 0.00% | – |
| Q4 2015 | $116,000 | +9.4% | 65,991 | +3.2% | 0.00% | – |
| Q3 2015 | $106,000 | -27.9% | 63,948 | -2.6% | 0.00% | – |
| Q2 2015 | $147,000 | +2.8% | 65,640 | +13.7% | 0.00% | – |
| Q1 2015 | $143,000 | – | 57,726 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 2,322,769 | $25,620,000 | 35.36% |
| Boxer Capital, LLC | 835,408 | $9,215,000 | 9.02% |
| Avoro Capital Advisors LLC | 1,416,257 | $15,621,000 | 5.45% |
| EcoR1 Capital, LLC | 950,000 | $10,479,000 | 3.66% |
| ACUTA CAPITAL PARTNERS, LLC | 500,000 | $5,515,000 | 3.08% |
| BVF INC/IL | 800,000 | $8,824,000 | 2.18% |
| Hatteras Investment Partners, LP | 70,720 | $780,000 | 2.13% |
| RA Capital Management | 1,414,114 | $15,598,000 | 1.99% |
| Connective Capital Management, LLC | 54,100 | $596,000 | 1.85% |
| Perceptive Advisors | 1,100,000 | $12,133,000 | 1.06% |